article = {COR-2020-9-107}
title = {Towards the Immunogenic Hyperthermic Action: Modulated ElectroHyperthermia}
journal = {Clinical Oncology and Research}
year = {2020}
issn = {2613-4942}
doi = {http://dx.doi.org/10.31487/j.COR.2020.09.07}
url = {https://www.sciencerepository.org/towards-the-immunogenic-hyperthermic-action-modulated-electro-hyperthermia_COR-2020-9-107 
author = {Andras  Szasz,}
keywords = {Hyperthermia, oncology, immunogenic cell death}
abstract ={Hyperthermia treatment for solid tumors is a long-used, but poorly accepted method in clinical use.
Modulated electro-hyperthermia (mEHT, trade name: oncothermia®) changes the paradigm, introduces a
novel, cellularly selective and immunogenic cell-ruination. The mEHT method produces tumor-vaccination,
presenting the unharmed genetic information of cancer cells to immune cells [1]. The mEHT method is
approved in more than 30 countries. Its phase II/III clinical applications indicate a broad perspective.}